期刊文献+

肿瘤干细胞和抗肿瘤药物研发思路 被引量:2

Tumor stem cells and strategies for research and development of new anticancer drugs
原文传递
导出
摘要 目前有些抗肿瘤药物尽管有较好的近期疗效,然而肿瘤患者单纯依赖化疗通常难以达到长期生存的目的。本文试图从肿瘤干细胞理论解释抗肿瘤药物近期疗效和远期生存之间存在的矛盾,并探讨抗肿瘤药物的研究发展方向。
出处 《军医进修学院学报》 CAS 2010年第12期1259-1261,共3页 Academic Journal of Pla Postgraduate Medical School
基金 中国博士后科学基金(20090461439) 河北省自然科学基金(C2009001195)~~
  • 相关文献

参考文献30

  • 1Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control [ J ] . J Natl Cancer Inst, 2003, 95 ( 17): 1276-1299.
  • 2Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells [ J ]. Nature, 2001, 414 ( 6859 ) : 105-111.
  • 3Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells [ J ] . Nature, 2004, 432 ( 7015 ) : 396-401.
  • 4Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ] . Proc Natl Acad Sci USA, 2003, 100 (7):3983-3988.
  • 5Hope K J, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity [ J ] . Nat Immunol, 2004, 5 ( 7 ) : 738-743.
  • 6Xin L, Lawson DA, Witte ON. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis [ J ] . Proc Natl Acad Sci U S A, 2005, 102 ( 19 ) : 6942-6947.
  • 7Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiafing cells [ J ] . Nature, 2007, 445 (7123): 111-115.
  • 8Mimeauh M, Hauke R, Mehta PP, et al. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers [ J ] . J Cell Mol Med, 2007, 11 (5): 981-1011.
  • 9Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [ J ] . Nat Rev Cancer, 2005, 5 ( 4 ) : 275-284.
  • 10Raaijmakers MH. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia [ J ] . Leukemia, 2007, 21 ( 10 ) : 2094-2102.

同被引文献82

  • 1钱其军,张琪.肿瘤靶向治疗的现状和展望[J].中国肿瘤生物治疗杂志,2006,13(4):239-242. 被引量:7
  • 2Feng Li,Benjamin Tiede,Joan Massague,Yibin Kang.Beyond tumorigenesis: cancer stem cells in metastasis[J].Cell Research,2007,17(1):3-14. 被引量:86
  • 3陈运贤,朱小玉.肿瘤治疗新目标——肿瘤干细胞[J].中国肿瘤,2007,16(7):518-520. 被引量:3
  • 4Conti CM, Angelucci D, Ferri M, Maccauro G, Caraffa A, Doyle R, et al. Relationship between cancer and psychology: An updated history. J Biol Regul Homeost Agents 2011; 25(3): 331-9.
  • 5Ciurea ME, Georgescu AM, Purcaru SO, Artene SA, Emami GH, Boldeanu MV, et al. Cancer stem cells: Biological functions and therapeutically targeting. Int J Mol Sci 2014; 15(5): 8169-85.
  • 6Reya T, Morrison S J, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414(6859): 105-11.
  • 7Bu Y, Cao D. The origin of cancer stem cells. Front Biosci (Schol Ed) 2012; 4: 819-30.
  • 8Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993; 7(3): 139-46.
  • 9Takao S, Ding Q, Matsubara S. Pancreatic cancer stem cells: Regulatory networks in the tumor microenvironment and targeted therapy. J Hepatobiliary Pancreat Sci 2012; 19(6): 614-20.
  • 10Cheng CY, Hwang CI, Corney DC, Flesken-Nikitin A, Jiang LC, Oner GM, et al. miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Reports 2014; 6(6): 1000-7.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部